Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer.

Ryan, Deborah; Carberry, Steven; Murphy, Áine C.; Lindner, Andreas U.; Fay, Joanna; Hector, Suzanne; McCawley, Niamh; Bacon, Orna; Concannon, Caoimhín G.; Kay, Elaine W.; McNamara, Deborah A.; Prehn, Jochen HM

Erratum to: Calnexin an ER stress-induced protein is a prognost.pdf (559.5 kB)

Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer.

Version 3 2022-11-29, 09:46

Version 2 2021-12-07, 10:47

Version 1 2019-11-22, 16:50

journal contribution

posted on 2019-11-22, 16:50 authored by Deborah Ryan, Steven Carberry, Áine C. Murphy, Andreas U. Lindner, Joanna Fay, Suzanne Hector, Niamh McCawley, Orna Bacon, Caoimhín G. Concannon, Elaine W. Kay, Deborah A. McNamara, Jochen HM Prehn

Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer.

Funding

Health Research Board. Science Foundation Ireland. European Union

History

Comments

The original article is available at www.biomedcentral.com

Published Citation

Ryan D, Carberry S, Murphy ÁC, Lindner AU, Fay J, Hector S, McCawley N, Bacon O, Concannon CG, Kay EW, McNamara DA, Prehn JH. Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer. Translational Medicine. 2016;14(1):222